Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Arch Dermatol Res ; 316(5): 174, 2024 May 17.
Article in English | MEDLINE | ID: mdl-38758250

ABSTRACT

Understanding patient non-adherence to prescribed antibiotics can inform clinical practices, patient counseling, and antibiotic efficacy study design in dermatology. The primary objective was to determine the rate of and reasons for antibiotic non-adherence in the dermatologic surgery setting. The secondary objective was to test the applicability of previously studied survey questions for antibiotic non-adherence screening in the dermatologic surgery setting. Five academic outpatient dermatologic surgery centers across the United States conducted one multicenter prospective cohort study. Dermatologic surgery patients ≥ 18 years of age who were prescribed an antibiotic were included as part of this study. 15.2% (42/276) of patients did not adhere to their antibiotic regimen after dermatologic surgery. Most common reasons for incomplete antibiotic courses included forgotten antibiotics (42.9%,18/42) and side effects (28.6%, 12/42). Previously evaluated questions to identify and predict non-adherence had modest performance in the dermatologic surgery setting (Area under the curve of 0.669 [95% CI (0.583-0.754)]). Antibiotic non-adherence after skin surgery is prevalent and commonly due to reasons that physicians can address with patients.


Subject(s)
Anti-Bacterial Agents , Medication Adherence , Humans , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/administration & dosage , Prospective Studies , Female , Middle Aged , Male , Medication Adherence/statistics & numerical data , Aged , Dermatologic Surgical Procedures/adverse effects , Surgical Wound Infection/prevention & control , Surgical Wound Infection/epidemiology , Adult , United States , Surveys and Questionnaires/statistics & numerical data
3.
J Clin Aesthet Dermatol ; 16(10): 59-64, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37915336

ABSTRACT

Objective: This review examines the current literature on the gut-skin connection in alopecia and summarizes interventions that impact hair growth by modulation of the gut or skin microbiome. Methods: PubMed searches were done to assess studies of the gut and skin microbiome and forms of alopecia including, alopecia areata (AA), androgenic alopecia (AGA), alopecia universalis (AU), central centrifugal cicatricial alopecia (CCCA) and lichen planopilaris (LPP). Filters were applied for human and animal studies. Articles not translated to English and studies assessing supplemental therapies on alopecia were excluded. Results: There is evidence that scalp, hair follicle, and gut microbiome alterations are associated with various types of alopecia. There is potential in the use of interventions targeting microbiome dysbiosis, including fecal transplants and probiotics. Limitations: This field of study still requires more high-quality research and studies with larger participant populations. Conclusion: Dysbiosis on the scalp, within the hair follicle and the gut seem to have a role in the pathophysiology of various forms of alopecia. There is evidence that interventions targeting dysbiosis may have potential in the treatment and management of hair loss. Further studies are needed to establish a direct connection and to clarify specific effects of these interventions.

5.
Dermatol Online J ; 27(9)2021 Sep 15.
Article in English | MEDLINE | ID: mdl-34755982

ABSTRACT

We present a 76-year old man who developed papulopustular rosacea after receiving nivolumab treatment for his esophageal carcinoma, metastatic to the lungs. Nivolumab is an emerging cancer therapy whose immune-related adverse events are still not fully recognized and likely underreported. The treatment has been reported to cause a myriad of cutaneous immune-related adverse events. However, nivolumab-induced-papulopustular rosacea has been scarcely reported. Thus, this case presents a clinically important finding that physicians should be aware of when seeing patients on nivolumab therapy.


Subject(s)
Antineoplastic Agents, Immunological/adverse effects , Carcinoma, Squamous Cell/drug therapy , Esophageal Neoplasms/drug therapy , Nivolumab/adverse effects , Rosacea/chemically induced , Aged , Antineoplastic Agents, Immunological/therapeutic use , Carcinoma, Squamous Cell/secondary , Esophageal Neoplasms/secondary , Facial Dermatoses/chemically induced , Humans , Male , Nivolumab/therapeutic use
6.
Dermatol Online J ; 27(4)2021 Apr 15.
Article in English | MEDLINE | ID: mdl-33999578

ABSTRACT

We present a patient with anti-MDA5 negative, anti-Ku positive clinically amyopathic dermatomyositis (CADM). A 61-year-old woman presented with a chief complaint of a 20-year history of a pruritic rash that was active on her face, chest, hands, legs, and back. A mildly scaly, erythematous, photo-distributed eruption along with slightly violaceous, scaly papules accentuated on the wrist, metacarpophalangeal joints, proximal interphalangeal and distal interphalangeal joints. Antibody profile was significant for positive ANA and anti-dsDNA, elevated anti-TIF-1gamma (RDL)/p155, and weakly positive anti Ku. Biopsy was consistent with dermatomyositis. Melanoma differentiation-associated gene 5 antibody (anti-MDA-5) has been identified as the most commonly associated autoantibody found in CADM and is associated with poor prognosis and a biomarker for the diagnosis of rapidly progressive interstitial lung disease. To our knowledge, our patient is the first case of negative anti-MDA-5 and anti-Ku positive CADM.


Subject(s)
Autoantibodies/blood , Autoimmune Diseases/diagnosis , Dermatomyositis/immunology , Interferon-Induced Helicase, IFIH1/immunology , Ku Autoantigen/immunology , Dermatomyositis/drug therapy , Dermatomyositis/pathology , Female , Humans , Methotrexate/therapeutic use , Middle Aged
7.
Nutrients ; 13(3)2021 Feb 27.
Article in English | MEDLINE | ID: mdl-33673587

ABSTRACT

BACKGROUND: Almonds have long been studied as a rich source of fatty acids, phytochemical polyphenols and antioxidants such as vitamin E. A recent study compared almond supplementations to a calorie-matched intervention for 16 weeks, yielding statistically significant improvement in wrinkle severity in postmenopausal women with Fitzpatrick skin types I and II that received almonds. This study furthers that assessment with a larger population and duration of 24 weeks to assess the influence of almond consumption on wrinkle severity, skin pigmentation and other skin biophysical profiles. OBJECTIVE: To investigate the effects of almond consumption on photoaging such as wrinkles and pigment intensity as well as facial biophysical parameters such as sebum production, skin hydration and water loss. DESIGN AND INTERVENTIONS: A prospective, randomized controlled study assessed postmenopausal women with Fitzpatrick skin types I or II who consumed 20% of their daily energy consumption in either almonds or a calorie-matched snack for 24 weeks. A facial photograph and image analysis system was used to obtain standardized high-resolution photographs and information on wrinkle width and severity at 0, 8, 16 and 24 weeks. Measurements of transepidermal water loss (TEWL), skin pigmentation, skin hydration and sebum production were also completed at each visit. RESULTS: The average wrinkle severity was significantly decreased in the almond intervention group at week 16 and week 24 compared to baseline by 15% and 16%, respectively. Facial pigment intensity was decreased 20% in the almond group at week 16 and this was maintained by week 24. There were no significant differences in skin hydration or TEWL in the almond group compared to the control, although sebum excretion was increased in the control group. CONCLUSION: The daily consumption of almonds may improve several aspects of photoaging such as facial wrinkles and pigment intensity in postmenopausal women. In conclusion, the daily consumption of almonds may contribute to the improvement of facial wrinkles and reduction of skin pigmentation among postmenopausal women with Fitzpatrick skin types I and II.


Subject(s)
Face , Prunus dulcis , Skin Aging , Skin Pigmentation , Aged , Aged, 80 and over , Diet , Dietary Supplements , Female , Humans , Middle Aged , Prospective Studies , Skin Physiological Phenomena , Snacks , Water Loss, Insensible/physiology
8.
Dermatol Online J ; 26(4)2020 Apr 15.
Article in English | MEDLINE | ID: mdl-32621692

ABSTRACT

Hidradenitis suppurativa is a chronic, painful disease that significantly reduces quality of life. Laser hair reduction is one modality that can be used in combination with other treatments to ameliorate the condition. We argue that insurance should provide coverage for this necessary service.


Subject(s)
Hair Removal/economics , Hidradenitis Suppurativa/economics , Insurance Coverage , Insurance, Health , Low-Level Light Therapy/economics , Hair/radiation effects , Hair Removal/methods , Hidradenitis Suppurativa/therapy , Humans , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...